Multi-institutional application of Failure Mode and Effects Analysis (FMEA) to CyberKnife Stereotactic Body Radiation Therapy (SBRT)

被引:51
|
作者
Veronese, Ivan [1 ]
De Martin, Elena [2 ]
Martinotti, Anna Stefania [3 ]
Fumagalli, Maria Luisa [2 ]
Vite, Cristina [3 ]
Redaelli, Irene [3 ]
Malatesta, Tiziana [4 ]
Mancosu, Pietro [5 ]
Beltramo, Giancarlo [3 ]
Fariselli, Laura [6 ]
Cantone, Marie Claire [1 ]
机构
[1] Univ Milan, Dipartimento Fis, I-20133 Milan, Italy
[2] UO Direzione Sanitaria, Fdn IRCCS Ist Neurol Carlo Besta Milan, Milan, Italy
[3] Reparto Cyberknife, Ctr Diagnostico Italiano, Milan, Italy
[4] UOC Fis Sanitaria AFAR, Osped San Giovanni Calibita Fatebenefratelli, Rome, Italy
[5] Ist Clin Humanitas, Reparto Radioterapia Oncolog, Milan, Italy
[6] Fdn IRCCS Ist Neurol Carlo Besta Milan, Unita Radioterapia, Milan, Italy
来源
RADIATION ONCOLOGY | 2015年 / 10卷
关键词
FMEA; SBRT; CyberKnife; Tracking; Liver; Spine; PROSTATE-CANCER; RADIOSURGERY; RADIOTHERAPY; EXPERIENCE; LESIONS;
D O I
10.1186/s13014-015-0438-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: A multidisciplinary and multi-institutional working group applied the Failure Mode and Effects Analysis (FMEA) approach to assess the risks for patients undergoing Stereotactic Body Radiation Therapy (SBRT) treatments for lesions located in spine and liver in two CyberKnife (R) Centres. Methods: The various sub-processes characterizing the SBRT treatment were identified to generate the process trees of both the treatment planning and delivery phases. This analysis drove to the identification and subsequent scoring of the potential failure modes, together with their causes and effects, using the risk probability number (RPN) scoring system. Novel solutions aimed to increase patient safety were accordingly considered. Results: The process-tree characterising the SBRT treatment planning stage was composed with a total of 48 sub-processes. Similarly, 42 sub-processes were identified in the stage of delivery to liver tumours and 30 in the stage of delivery to spine lesions. All the sub-processes were judged to be potentially prone to one or more failure modes. Nineteen failures (i.e. 5 in treatment planning stage, 5 in the delivery to liver lesions and 9 in the delivery to spine lesions) were considered of high concern in view of the high RPN and/or severity index value. Conclusions: The analysis of the potential failures, their causes and effects allowed to improve the safety strategies already adopted in the clinical practice with additional measures for optimizing quality management workflow and increasing patient safety.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Multi-institutional application of Failure Mode and Effects Analysis (FMEA) to CyberKnife Stereotactic Body Radiation Therapy (SBRT)
    Ivan Veronese
    Elena De Martin
    Anna Stefania Martinotti
    Maria Luisa Fumagalli
    Cristina Vite
    Irene Redaelli
    Tiziana Malatesta
    Pietro Mancosu
    Giancarlo Beltramo
    Laura Fariselli
    Marie Claire Cantone
    Radiation Oncology, 10
  • [2] Stereotactic body radiation therapy (SBRT) for metastatic renal cell carcinoma: A multi-institutional experience
    Singh, Raj
    Ansinelli, Hayden
    Sharma, Dana
    Jenkins, Jan
    Davis, Joanne
    Sharma, Sanjeev
    Vargo, John Austin
    JOURNAL OF RADIOSURGERY AND SBRT, 2020, 7 (01): : 29 - 37
  • [3] Stereotactic Body Radiation Therapy for Unbiopsied Early-stage Lung Cancer A Multi-Institutional Analysis
    Harkenrider, Matthew M.
    Bertke, Matthew H.
    Dunlap, Neal E.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (04): : 337 - 342
  • [4] Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases
    Rusthoven, Kyle E.
    Kavanagh, Brian D.
    Cardenes, Higinia
    Stieber, Volker W.
    Burri, Stuart H.
    Feigenberg, Steven J.
    Chidel, Mark A.
    Pugh, Thomas J.
    Franklin, Wilbur
    Kane, Madeleine
    Gaspar, Laurie E.
    Schefter, Tracey E.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (10) : 1572 - 1578
  • [5] Stereotactic Body Radiation Therapy (SBRT) for Spinal Metastases Real-world Outcomes From an International Multi-institutional SBRT Registry
    Singh, Raj
    Valluri, Anisha
    Jenkins, Jan
    Davis, Joanne
    Vargo, John A.
    Sharma, Sanjeev
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2022, 45 (05): : 196 - 201
  • [6] Stereotactic Body Radiation Therapy (SBRT) Using CyberKnife in Oligometastatic Cancer Patients; Retrospective Evaluation, Single Institution Experience
    Alsuhaibani, Abdullah
    Elashwah, Ahmed
    Alkafi, Abdullah
    Constantinescus, Camelia
    ALzorkany, Faisal
    JOURNAL OF GASTROINTESTINAL CANCER, 2019, 50 (04) : 879 - 887
  • [7] Dose fall-off during the treatment of thoracic spine metastasis with CyberKnife stereotactic body radiation therapy (SBRT)
    Ju, Zhongjian
    Wang, Jingyuan
    Zhang, Huaiwen
    Du, Lei
    Xu, Wei
    Wang, Xiaoshen
    Ge, Ruigang
    Li, Jiwei
    Zheng, Qingzeng
    Li, Jianxiong
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2020, 20 (01) : 131 - 139
  • [8] Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation
    Jawad, Maha Saada
    Fahim, Daniel K.
    Gerszten, Peter C.
    Flickinger, John C.
    Sahgal, Arjun
    Grills, Inga S.
    Sheehan, Jason
    Kersh, Ronald
    Shin, John
    Oh, Kevin
    Mantel, Frederick
    Guckenberger, Matthias
    JOURNAL OF NEUROSURGERY-SPINE, 2016, 24 (06) : 928 - 936
  • [9] Stereotactic body radiation therapy for low and intermediate risk prostate cancer-Results from a multi-institutional clinical trial
    Hannan, Raquibul
    Tumati, Vasu
    Xie, Xian-Jin
    Cho, L. Chinsoo
    Kavanagh, Brian D.
    Brindle, Jeffrey
    Raben, David
    Nanda, Akash
    Cooley, Susan
    Kim, D. W. Nathan
    Pistenmaa, David
    Lotan, Yair
    Timmerman, Robert
    EUROPEAN JOURNAL OF CANCER, 2016, 59 : 142 - 151
  • [10] Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases
    Rusthoven, Kyle E.
    Kavanagh, Brian D.
    Burri, Stuart H.
    Chen, Changhu
    Cardenes, Higinia
    Chidel, Mark A.
    Pugh, Thomas J.
    Kane, Madeleine
    Gaspar, Laurie E.
    Schefter, Tracey E.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (10) : 1579 - 1584